Intravenous Iron Optimizes the Response to Recombinant Human Erythropoietin in Cancer Patients With Chemotherapy-Related Anemia: A Multicenter, Open-Label, Randomized Trial - Concepedia

Concepedia

Publication | Closed Access

Intravenous Iron Optimizes the Response to Recombinant Human Erythropoietin in Cancer Patients With Chemotherapy-Related Anemia: A Multicenter, Open-Label, Randomized Trial

409

Citations

24

References

2004

Year

Michael Auerbach, Harold S. Ballard, J. Richard Trout, Marilyn McIlwain, Alan Ackerman, Huzefa Bahrain, Stefan Balan, Lance Barker, Jeevindra Rana

Journal of Clinical Oncology

Abstract

rHuEPO increases Hb levels and improves QOL in patients with chemotherapy-related anemia. Magnitude of Hb increase and QOL improvement is significantly greater if IV iron is added.

References

	Year	Citations

Page 1